globenewswire

Evotec FY 2013: Execute on Innovate to Create Value Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 20:58
HAMBURG, Germany, March 25, 2014 (GLOBE NEWSWIRE)
Read more...
 
Advaxis Appoints Sara Bonstein as Chief Financial Officer, Senior Vice President Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 11:15
PRINCETON, N.J., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Chimerix to Present a Summary of Brincidofovir's (CMX001) Hematologic Safety at the Annual Meeting of the European Group for Blood and Marrow Transplantation Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 10:15
DURHAM, N.C., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Vitacost.com Announces Appointment of New Independent Director Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 10:05
BOCA RATON, Fla., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 10:05
NEW YORK and LONDON, March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Blueprint Medicines to Present on the First Isoform Selective FGFR4 Inhibitor at the AACR Annual Meeting 2014 Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 10:01
CAMBRIDGE, Mass., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 10:01
FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Capstone Therapeutics Announces Operating Update Conference Call Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 08:29
TEMPE, Ariz.--Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT.
Read more...
 
Cellular Biomedicine Group Releases Positive Results From Phase I Clinical Trial for Hepatocellular Carcinoma Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 06:53
PALO ALTO, Calif., March 24, 2014 (GLOBE NEWSWIRE)
Read more...
 
Independence Blue Cross study in The American Journal of Managed Care finds lower costs for those with chronic illness treated in patient-centered medical homes Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 06:40
PHILADELPHIA--Results from a three-year study by Independence Blue Cross (IBC) demonstrating reduced costs and utilization for high-risk patients cared for by patient-centered medical homes appear today in The American Journal of Managed Care.
Read more...
 
Biocept Appoints Commercialization Leader to Implement Global Diagnostic Sales Program Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 05:04
SAN DIEGO--Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA) and biomarker analysis, today announced that it has appointed Raaj Trivedi as Vice President - Commercial Operations.
Read more...
 
Autism Speaks Canada Grants over $450,000 Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 03:05
TORONTO--Autism Speaks Canada proudly provides funding for not-for-profit service providers across Canada through the Family Services Community Grants.
Read more...
 
EHNAC, in Partnership With the Texas Health Services Authority, Releases TX-HIE Accreditation Program Criteria for Public Review Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 03:04
The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization, and the Texas Health Services Authority (THSA) today announced the posting of TX-HIE accreditation program criteria for public review.
Read more...
 
United-Guardian Reports Record Sales & Earnings Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 03:00
HAUPPAUGE, N.Y.--United-Guardian, Inc., (Nasdaq:UG) announced today that both earnings and sales set new company records in FY-2013.
Read more...
 
Ultragenyx Reports Fourth Quarter and Print E-mail
By GLOBE NEWSWIRE   
Monday, 24 March 2014 03:00
NOVATO, Calif.--Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and

Error. Page cannot be displayed. Please contact your service provider for more details. (30)

ultra-rare diseases, today reported its financial results and business highlights for the fourth quarter and year ended December 31, 2013.
Read more...
 
<< Start < Prev 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 Next > End >>

Page 1443 of 1555

Newsletter

BMR:1